ALR Technologies

ALR Technologies is a digital health company focusing on diabetes management through cloud-based, FDA-cleared, HIPAA-compliant systems. It is transitioning from blood glucose meter-based solutions to integrate cost-effective continuous glucose monitors (CGMs) for both human and animal health. Its ALRT Diabetes Solution for humans includes remote patient monitoring, a predictive A1C algorithm, and insulin dosing adjustment software. For the veterinary market, its GluCurve Pet CGM is in late-stage development for diabetic cats and dogs, with commercial manufacturing starting in 2025. The company aims to enable remote diabetes care, reduce clinical inertia, and improve adherence.